Basics Tarsus Pharmaceuticals, Inc. Common Stock IPO Date: October 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.7B Activated in VL: True Average Daily Range Avg Daily Range: $0.74 | 2.75% Avg Daily Range (30 D): $0.68 | 1.65% Avg Daily Range (90 D): $0.98 | 2.16% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .43M Avg Daily Volume (90 D): .5M Trade Size Avg Trade Size (Sh.): 59 Avg Trade Size (Sh.) (30 D): 46 Avg Trade Size (Sh.) (90 D): 48 Institutional Trades Total Inst.Trades: 1,202 Avg Inst. Trade: $2.71M Avg Inst. Trade (30 D): $3.38M Avg Inst. Trade (90 D): $3.15M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.76M Avg Closing Trade (30 D): $4.55M Avg Closing Trade (90 D): $4.49M Avg Closing Volume: 78.97K     News May 29, 2025 @ 9:00 PM Tarsus to Participate in Upcoming Investor Confere... Source: N/A May 5, 2025 @ 8:40 PM Elanco Animal Health Sells Xdemvy Royalties To Bla... Source: Vandana Singh Apr 24, 2025 @ 9:00 PM Tarsus to Report First Quarter 2025 Financial Resu... Source: N/A Mar 13, 2025 @ 1:49 AM Tarsus Announces Pricing of Upsized $125.0 Million... Source: N/A Mar 6, 2025 @ 10:00 PM Tarsus to Participate in Upcoming Investor Confere... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-.64 $-.59 $-3.07 Diluted EPS $-.64 $-.59 $-3.07 Revenue $ 78.34M $ 66.41M $ 182.95M Gross Profit $ $ $ Net Income / Loss $ -25.12M $ -23.11M $ -115.55M Operating Income / Loss $ -26.28M $ -24.42M $ -120.57M Cost of Revenue $ $ $ Net Cash Flow $ 80.97M $ -78.83M $ -127.57M PE Ratio